TTK Healthcare Limited - Asset Resilience Ratio
TTK Healthcare Limited (TTKHLTCARE) has an Asset Resilience Ratio of 71.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read TTKHLTCARE liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2025)
This chart shows how TTK Healthcare Limited's Asset Resilience Ratio has changed over time. See TTK Healthcare Limited (TTKHLTCARE) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down TTK Healthcare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TTK Healthcare Limited market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs6.01 Billion | 46.38% |
| Short-term Investments | Rs3.31 Billion | 25.53% |
| Total Liquid Assets | Rs9.32 Billion | 71.91% |
Asset Resilience Insights
- Very High Liquidity: TTK Healthcare Limited maintains exceptional liquid asset reserves at 71.91% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
TTK Healthcare Limited Industry Peers by Asset Resilience Ratio
Compare TTK Healthcare Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AbbVie Inc
NYSE:ABBV |
Drug Manufacturers - General | 0.02% |
|
Roche Holding AG
SW:ROG |
Drug Manufacturers - General | 15.37% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
CSPC Pharmaceutical Group Limited
F:CVG |
Drug Manufacturers - General | 4.64% |
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.03% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 10.10% |
Annual Asset Resilience Ratio for TTK Healthcare Limited (2005–2025)
The table below shows the annual Asset Resilience Ratio data for TTK Healthcare Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 66.04% | Rs8.46 Billion ≈ $91.50 Million |
Rs12.81 Billion ≈ $138.56 Million |
-3.72pp |
| 2024-03-31 | 69.76% | Rs8.38 Billion ≈ $90.57 Million |
Rs12.01 Billion ≈ $129.84 Million |
-1.80pp |
| 2023-03-31 | 71.56% | Rs8.37 Billion ≈ $90.56 Million |
Rs11.70 Billion ≈ $126.54 Million |
+25.35pp |
| 2022-03-31 | 46.21% | Rs2.58 Billion ≈ $27.92 Million |
Rs5.59 Billion ≈ $60.40 Million |
+2.19pp |
| 2021-03-31 | 44.02% | Rs2.18 Billion ≈ $23.53 Million |
Rs4.94 Billion ≈ $53.45 Million |
+15.28pp |
| 2020-03-31 | 28.74% | Rs1.24 Billion ≈ $13.40 Million |
Rs4.31 Billion ≈ $46.63 Million |
+1.19pp |
| 2019-03-31 | 27.55% | Rs1.15 Billion ≈ $12.39 Million |
Rs4.16 Billion ≈ $44.97 Million |
+5.79pp |
| 2018-03-31 | 21.76% | Rs886.21 Million ≈ $9.58 Million |
Rs4.07 Billion ≈ $44.05 Million |
+19.23pp |
| 2017-03-31 | 2.53% | Rs72.43 Million ≈ $783.27K |
Rs2.86 Billion ≈ $30.98 Million |
-0.82pp |
| 2016-03-31 | 3.35% | Rs101.34 Million ≈ $1.10 Million |
Rs3.03 Billion ≈ $32.72 Million |
+3.30pp |
| 2015-03-31 | 0.05% | Rs1.34 Million ≈ $14.46K |
Rs2.75 Billion ≈ $29.76 Million |
-0.01pp |
| 2014-03-31 | 0.06% | Rs1.34 Million ≈ $14.46K |
Rs2.40 Billion ≈ $25.95 Million |
-0.31pp |
| 2013-03-31 | 0.37% | Rs7.68 Million ≈ $83.07K |
Rs2.09 Billion ≈ $22.64 Million |
-2.80pp |
| 2012-03-31 | 3.17% | Rs67.68 Million ≈ $731.94K |
Rs2.13 Billion ≈ $23.08 Million |
-11.58pp |
| 2011-03-31 | 14.75% | Rs285.40 Million ≈ $3.09 Million |
Rs1.93 Billion ≈ $20.92 Million |
+0.98pp |
| 2010-03-31 | 13.78% | Rs212.75 Million ≈ $2.30 Million |
Rs1.54 Billion ≈ $16.70 Million |
+1.44pp |
| 2009-03-31 | 12.34% | Rs170.43 Million ≈ $1.84 Million |
Rs1.38 Billion ≈ $14.94 Million |
+2.11pp |
| 2008-03-31 | 10.22% | Rs121.77 Million ≈ $1.32 Million |
Rs1.19 Billion ≈ $12.88 Million |
+3.95pp |
| 2007-03-31 | 6.27% | Rs64.73 Million ≈ $700.08K |
Rs1.03 Billion ≈ $11.16 Million |
+1.72pp |
| 2006-03-31 | 4.55% | Rs41.65 Million ≈ $450.47K |
Rs916.13 Million ≈ $9.91 Million |
+0.33pp |
| 2005-03-31 | 4.21% | Rs39.17 Million ≈ $423.56K |
Rs929.63 Million ≈ $10.05 Million |
-- |
About TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, anti… Read more